In 2017, the United Kingdom was the 2nd European ODA donor in volume as its ODA represented USD 18.05 billion. In the past few years, ODA in volume has gradually reduced as it equaled USD 19.3 billion in 2014 and USD 18.7 billion in 2015. Nevertheless, the UK is one of the few European countries that have reached the target of allocating 0.7% of their GNI to ODA, and that is complying with the recommendation of the WHO Commission on Macroeconomics and Health unlike other European members of the DAC such as France and Germany.
Although the UK reaches the 0.1% recommendation of WHO, it is interesting to note that this has been steadily decreasing since 2013 when DAH represented 0.16% of UK’s GNI.
Since the CRS database does not allow providing multiple recipients for one activity, all the multi-countries or multi-regions projects are reported as “unspecified”.
Therefore, only 63% of total bilateral DAH could be allocable by income in 2016. On average during the period 2014-2016, the UK allocated around 38% to low-income countries, around 23% to lower-middle-income countries and around 1.6% to upper-middle-income countries (the remaining 37.2% being impossible to allocate).